ATE286407T1 - Verfahren zur inaktivierung von pathogenen mittels breitspektrum-pulslicht - Google Patents

Verfahren zur inaktivierung von pathogenen mittels breitspektrum-pulslicht

Info

Publication number
ATE286407T1
ATE286407T1 AT00910149T AT00910149T ATE286407T1 AT E286407 T1 ATE286407 T1 AT E286407T1 AT 00910149 T AT00910149 T AT 00910149T AT 00910149 T AT00910149 T AT 00910149T AT E286407 T1 ATE286407 T1 AT E286407T1
Authority
AT
Austria
Prior art keywords
broad
composition
content
spectrum
pathogens
Prior art date
Application number
AT00910149T
Other languages
English (en)
Inventor
H William Cover
Jeffrey M Boeger
Catriona J Mcdonald
Sean Maloy
Andrew Hugh Bushnell
James Randall Cooper
Original Assignee
Purepulse Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purepulse Technologies Inc filed Critical Purepulse Technologies Inc
Application granted granted Critical
Publication of ATE286407T1 publication Critical patent/ATE286407T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10—Apparatus features
    • A61L2202/11—Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Eye Examination Apparatus (AREA)
AT00910149T 1999-02-13 2000-02-11 Verfahren zur inaktivierung von pathogenen mittels breitspektrum-pulslicht ATE286407T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12003499P 1999-02-13 1999-02-13
US32901899A 1999-06-09 1999-06-09
PCT/US2000/003546 WO2000047240A1 (en) 1999-02-13 2000-02-11 Methods of inactivating pathogens using broad-spectrum pulsed light

Publications (1)

Publication Number Publication Date
ATE286407T1 true ATE286407T1 (de) 2005-01-15

Family

ID=26818000

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00910149T ATE286407T1 (de) 1999-02-13 2000-02-11 Verfahren zur inaktivierung von pathogenen mittels breitspektrum-pulslicht

Country Status (13)

Country Link
EP (1) EP1152773B1 (de)
JP (1) JP2002536424A (de)
KR (1) KR100630520B1 (de)
CN (1) CN1344170A (de)
AT (1) ATE286407T1 (de)
AU (1) AU779193B2 (de)
BR (1) BR0008211A (de)
CA (1) CA2360131A1 (de)
DE (1) DE60017243T2 (de)
MX (1) MXPA01008170A (de)
NO (1) NO20013918L (de)
RU (1) RU2001125094A (de)
WO (1) WO2000047240A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7068361B2 (en) 1999-06-03 2006-06-27 Baxter International Apparatus, systems and methods for processing and treating a biological fluid with light
US6565802B1 (en) 1999-06-03 2003-05-20 Baxter International Inc. Apparatus, systems and methods for processing and treating a biological fluid with light
US6843961B2 (en) 2000-06-15 2005-01-18 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
AU2001266788A1 (en) * 2000-06-20 2002-01-02 Purepulse Technologies, Inc. The inactivation of nucleic acids using broad-spectrum pulsed light
US20020176796A1 (en) * 2000-06-20 2002-11-28 Purepulse Technologies, Inc. Inactivation of microbes in biological fluids
WO2002026270A2 (en) * 2000-09-27 2002-04-04 Gambro, Inc. Inactivation of contaminants using photosensitizers and pulsed light
US7381976B2 (en) * 2001-03-13 2008-06-03 Triton Thalassic Technologies, Inc. Monochromatic fluid treatment systems
US6613505B2 (en) 2001-04-12 2003-09-02 Bioresource International, Inc. Composition and method for destruction of infetious prion proteins
FR2947456B1 (fr) * 2009-07-06 2012-03-09 Univ Bordeaux 1 Procede d'inactivation d'au moins un agent pathogene dans un echantillon de plasma sanguin humain
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
EP2583677A3 (de) 2011-10-21 2013-07-03 Abbvie Inc. Verfahren zur Behandlung von HCV mit wenigstens zwei direkt angreifenden viralen Mitteln, Ribavirin aber nicht Interferon.
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
DE202012012955U1 (de) 2011-10-21 2014-07-14 Abbvie Inc. Eine Kombination aus mindestens zwei direkt wirkenden antiviralen Wirkstoffen (DAAs) für die Verwendung zur Behandlung von HCV
EA201892448A1 (ru) 2016-04-28 2019-06-28 Эмори Юниверсити Алкинсодержащие нуклеотидные и нуклеозидные терапевтические композиции и связанные с ними способы применения
JP2021506931A (ja) * 2017-12-20 2021-02-22 クック リージェンテック エルエルシーＣｏｏｋ Ｒｅｇｅｎｔｅｃ Ｌｌｃ 病原体減少血小板組成物および関連方法
CN116732125A (zh) * 2021-11-24 2023-09-12 湖北瑞邦生物科技有限公司 一种提高桑叶肽降血糖活性的提取方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034235A (en) * 1983-11-23 1991-07-23 Maxwell Laboratories, Inc. Methods for presevation of foodstuffs
AU3849685A (en) * 1984-02-16 1985-08-22 Molecular Biophysics Technology, Inc. Pusled light selective photcysis for sterilization of biological fluid
AU2887495A (en) * 1994-06-25 1996-01-19 Opperbas Holding B.V. A method of virus inactivation in samples by uv irradiation

Also Published As

Publication number Publication date
KR20010108199A (ko) 2001-12-07
AU3229100A (en) 2000-08-29
CN1344170A (zh) 2002-04-10
DE60017243T2 (de) 2005-12-08
EP1152773B1 (de) 2005-01-05
KR100630520B1 (ko) 2006-09-29
NO20013918D0 (no) 2001-08-10
NO20013918L (no) 2001-10-12
AU779193B2 (en) 2005-01-13
EP1152773A1 (de) 2001-11-14
WO2000047240A1 (en) 2000-08-17
CA2360131A1 (en) 2000-08-17
MXPA01008170A (es) 2002-04-24
DE60017243D1 (de) 2005-02-10
BR0008211A (pt) 2001-11-06
RU2001125094A (ru) 2003-09-27
JP2002536424A (ja) 2002-10-29

Similar Documents

Publication Publication Date Title
ATE286407T1 (de) Verfahren zur inaktivierung von pathogenen mittels breitspektrum-pulslicht
DE69027187D1 (de) Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
Yoshida et al. Peripheral blood mononuclear cells enhance the anabolic effects of platelet‐rich plasma on anterior cruciate ligament fibroblasts
KR102671387B1 (ko) 혈소판 용해질을 멸균시키기 위한 방법
ATE217144T1 (de) Verfahren und zusammensetzungen zur selektiven modifikation von nukleinsaeuren
DE60043271D1 (de) Methoden und Zusammensetzungen zur Heilung und Reparatur von Gelenkknorpeln
CY1118467T1 (el) Σκευασματα αντισωματων και πρωτεϊνων υψηλης συγκεντρωσης
ATE410441T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidinanalogen
DE69328685D1 (de) Verfahren zur inaktivierung von bakterien in blutpräparaten mit hilfe von methoxypsoralen
DE69835279D1 (de) Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika
DE69325948D1 (de) Entfernung von Antikörpern aus von Blut stammenden Zusammensetzungen unter Erhalt von Gerinnungsfaktoren
ATE243198T1 (de) Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenen
ATE149355T1 (de) Verfahren zur inaktivierung von prionen
ATE301186T1 (de) Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt
Burnouf et al. Viral safety of human platelet lysate for cell therapy and regenerative medicine: moving forward, yes, but without forgetting the past
Burnouf et al. Blood‐derived biomaterials: fibrin sealant, platelet gel and platelet fibrin glue
Cinotti et al. Bone ingrowth and vascular supply in experimental spinal fusion with platelet-rich plasma
US20090214382A1 (en) Methods of sterilizing biological mixtures using alpha-keto acids
ATE546155T1 (de) Verfahren zur stabilisierung eines kryopräzipitats von plasmatischen proteinen für eine wärmebehandlung zur viralen inaktivierung
Su et al. A virally inactivated functional growth factor preparation from human platelet concentrates
DE59711375D1 (de) Verfahren zur aktivierung von denaturiertem protein
ATE255920T1 (de) Methoden und zusammensetzungen zur heilung und reparatur von gelenkknorpeln
Chou et al. Current methods to manufacture human platelet lysates for cell therapy and tissue engineering: possible trends in product safety and standardization
DE602005019998D1 (de) Verfahren zur sterilisation von biologischen präparaten
DE59707067D1 (de) Verfahren zur inaktivierung von lipidumhüllten viren mit lipopeptiden und neue antivirale lipopeptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties